Kidney TransplantationArchives
Prehabilitation interventions to support the postoperative recovery of adult kidney transplant candidates: a scoping review
Kidney Transplantation 5 min.
Approximately four million Canadians are affected by chronic kidney disease (CKD) [1]. CKD is a gradual loss of kidney function over time which can progress to end stage kidney disease (ESKD), a condition that affects about 48,375 Canadians [2]. While there is no cure for kidney failure, renal replacement...
Evaluation of everolimus pharmacokinetic monitoring based on trough concentration and area under the blood concentration time curve in kidney transplantation
Kidney Transplantation 4 min.
Everolimus (EVR) is a proliferation-signal inhibitor developed as an immunosuppressive therapy following solid-organ transplantation. Among kidney transplant recipients (KTRs), calcineurin inhibitor (CNI)-associated nephrotoxicity remains a major barrier to long-term graft survival. EVR has emerged as...
Safety of biologic therapy in kidney and liver transplant recipients with systemic inflammatory diseases: a real-world study from Israel
Kidney Transplantation 1 min.
Safety is a concern for solid-organ transplant (SOT) recipients with systemic inflammatory diseases (SIDs) treated with biologic therapy. This study evaluated the safety of biologic therapy in SOT recipients with SIDs. Methods: This retrospective study between 2000 and 2024 included 20 biologic-treated...
It never rains but pours: disseminated nocardiosis in a renal transplant patient from Nigeria – a case report
Kidney Transplantation 5 min.
Nocardia are ubiquitous Gram-positive, acid-fast bacteria found worldwide in soil and both fresh- and saltwater. The main route of infection is inhalation [1] but primary cutaneous infection can also occur following traumatic inoculation [2]. These environmental organisms were first described by French...
